These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10740133)
1. Current perspectives on the design of phase II trials of new drugs for the treatment of heart failure. Packer M Am Heart J; 2000 Apr; 139(4):S202-6. PubMed ID: 10740133 [No Abstract] [Full Text] [Related]
2. Design of phase II trials in congestive heart failure. DeMets DL Am Heart J; 2000 Apr; 139(4):S207-10. PubMed ID: 10740134 [No Abstract] [Full Text] [Related]
3. Pharmacological treatment of acute heart failure: current treatment and new targets. Pöss J; Link A; Böhm M Clin Pharmacol Ther; 2013 Oct; 94(4):499-508. PubMed ID: 23863875 [TBL] [Abstract][Full Text] [Related]
4. Treatment of diastolic heart failure. Dhir SK Mayo Clin Proc; 2002 Mar; 77(3):295-6. PubMed ID: 11888037 [No Abstract] [Full Text] [Related]
5. Whither Withering's Legacy? Digoxin's role in our contemporary pharmacopeia for heart failure. Young JB J Am Coll Cardiol; 2005 Aug; 46(3):505-7. PubMed ID: 16053965 [No Abstract] [Full Text] [Related]
6. Clinical use of inotropic therapy for heart failure: looking backward or forward? Part II: chronic inotropic therapy. Stevenson LW Circulation; 2003 Jul; 108(4):492-7. PubMed ID: 12885733 [No Abstract] [Full Text] [Related]
7. Newer drugs for heart failure: hype or hope? Ghali JK Expert Opin Investig Drugs; 2017 Jan; 26(1):5-7. PubMed ID: 27828719 [No Abstract] [Full Text] [Related]
8. Improving clinical outcomes with drug treatment in heart failure: what have trials taught? Konstam MA Am J Cardiol; 2003 Mar; 91(6A):9D-14D. PubMed ID: 12670637 [TBL] [Abstract][Full Text] [Related]
10. Risk of death with nesiritide. Burger AJ JAMA; 2005 Aug; 294(8):897; author reply 898. PubMed ID: 16118377 [No Abstract] [Full Text] [Related]
11. Rationale and design of the enoximone clinical trials program. Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960 [TBL] [Abstract][Full Text] [Related]
12. [Drug therapy of heart failure]. Hennersdorf M; Schwartzkopff B; Strauer BE Internist (Berl); 2000 Apr; 41 Suppl 1():S2-12. PubMed ID: 10840659 [No Abstract] [Full Text] [Related]
13. [Therapy of ischemic and nonischemic heart failure. Current status and prospects]. Weil J; Riegger G Internist (Berl); 2002 Apr; 43 Suppl 1():S8, S11-8. PubMed ID: 11993003 [No Abstract] [Full Text] [Related]
14. [Risk factors for dying among ibopamine users]. Vandenbroucke JP Ned Tijdschr Geneeskd; 1999 Jul; 143(31):1631-2. PubMed ID: 10488378 [No Abstract] [Full Text] [Related]
15. [Risk factors for dying among ibopamine users]. de Graeff PA; Elferink AJ; Lekkerkerker JF Ned Tijdschr Geneeskd; 1999 May; 143(21):1114-5. PubMed ID: 10368748 [No Abstract] [Full Text] [Related]